Upcoming Events
The Scientist’s Journal Club
Learn about linking cell secretions to their transcriptomes using SEC-seq.
Applying Nanovial Technology to Discover Rare T Cell Receptors
“Lab on a particle” technologies, such as Nanovials, are emerging as an accessible platform for performing single-cell functional screening leveraging standard instrumentation, such as flow cytometers and microfluidic single-cell sequencing platforms. Learn about our progress in using Nanovial particles for discovery of monoclonal antibodies and the characterization and discovery of antigen-specific and metabolite-specific T cells.
Accelerating the Discovery of Monoclonal Antibodies (mAbs) and T-cell Receptors (TCRs) using Lab on a Particle Technology
“Lab on a particle” technologies, such as Nanovials, are emerging as an accessible platform for performing single-cell functional screening leveraging standard instrumentation, such as flow cytometers and microfluidic single-cell sequencing platforms. Learn about our progress in using Nanovial particles for discovery of monoclonal antibodies and the characterization and discovery of antigen-specific and metabolite-specific T cells.
Antibody Engineering & Therapeutics 2023
Stop by booth #604 at the conference for Antibody Engineering & Therapeutics
Fully Human Antibody Discovery Using Nanovials and Plasma Cells From ATX-GKTM Mice
Pairing Alloy Therapeutics’ best-in-class transgenic humanized mouse with Partillion Biosciences’ Nanovial technology provides a simple and cost-efficient method to perform high throughput screens of antibody secreting plasma cells for the discovery of antigen-specific antibodies. In this webinar, we demonstrate an antibody discovery workflow that yields diverse, high affinity binders with development potential in therapeutic settings.
Next-generation Nanovial Platforms for Function-first Discovery of Rare Antibodies and T-cell Receptors
By providing functional annotation in a high-throughput manner, Nanovials speed up the discovery of antibodies and cancer-specific TCRs, revolutionizing therapeutic antibody and T cell therapy development.
Accelerating the Discovery of Rare Antibodies and T-cell Receptors (TCRs) using Lab on a Particle Technology
“Lab on a particle” technologies, such as Nanovials, are emerging as an accessible platform for performing single-cell functional screening leveraging standard instrumentation, such as flow cytometers and microfluidic single-cell sequencing platforms. Learn about our progress in using Nanovial particles for discovery of monoclonal antibodies and the characterization and discovery of antigen-specific and metabolite-specific T cells.
Caltech Bioscience Industry Day 2023
Come say hi at the Caltech Bioscience Industry Day, a flagship event of the Caltech Bioscience Industrial Partners Program (CBIPP), for a day of inspiring discussions, industry connections, and cutting-edge innovations in biodata, biopharma, biotech, life sciences, medical devices, and synthetic biology.
Nanovials and Single Cell Analysis: Fast-Tracking Antibody Discovery
Don't miss our upcoming webinar to learn how to streamline your antibody discovery workflows.